Tumor suppressive microrna-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma

Oncotarget

Volumn 3, Issue 1, 2012, Pages 44-57

  Hidaka, Hideo ^a   Seki, Naohiko ^b   Yoshino, Hirofumi ^a   Yamasaki, Takeshi ^a   Yamada, Yasutoshi ^a   Nohata, Nijiro ^b   Fuse, Miki ^b   Nakagawa, Masayuki ^a   Enokida, Hideki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Expression signature; MicroRNA; MiR 1285; Renal cell carcinoma; Transglutaminase 2; Tumor suppressor

Indexed keywords

MICRORNA; MIRN1285 MICRORNA, HUMAN;

ARTICLE; CANCER INVASION; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MICROARRAY ANALYSIS; PATHOLOGY; PHYSIOLOGY; TISSUE MICROARRAY; TUMOR CELL LINE; TUMOR GENE; TUMOR SUPPRESSOR GENE;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY NEOPLASMS; MICROARRAY ANALYSIS; MICRORNAS; NEOPLASM INVASIVENESS; TISSUE ARRAY ANALYSIS;

EID: 84861905586     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.417     Document Type: Article

References (40)

1. Weng L, Wu X, Gao H, Bing Mu, Xuejun Li, Jin-Hui Wang, Chao Guo, Jennifer M Jin, Zhuo Chen, Covrrubias M, Yuan YC, Weiss LM and Huiquing Wu. MicorRNA profiling of clear cell renal carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin embedded tissue specimens. J Pathol 2010;222:41-51.
2. Fridman E, Dotan Z, Barshack I, Barshak I, David MB, Dov A, Tbak S, Zion O, Benjamin S, Benjamin H, Kuker H, Camila Avivi, Rosenblatt K, Sylvie PC, Ramon J. Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 2010;12:687-696.
3. Aben KK, Luth TK, Jassen-Heijinen ML, Mulders PF, Kiemeney DJ, Spronsen DJ. No improvement in renal cell carcinoma survival: a population-based study in The Netherlands. Eur J Cancer 2008;44:1701-1709.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
5. Calin GA, Croce CM. MicroRNA signature in human cancers. Nat Rev Cancer 2006;6:857-866
6. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;9:102-114.
7. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Taujimoto G, Nakagawa M, Seki N. Identification of novel microRNA targets based on microRNA signature in bladder cancer. Int J cancer 2009;125:345-352.
8. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsuda H. miR-145, miR-133a and miR-133b: tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J cancer 2010;103:877-884.
9. Kikkawa N, Hanazawa T, Fujimaru L, Nohata N, Suzuki H, Chazono H, Sakurai D, Horiguchi S, Okamoto Y, Seki N. miR-489 is a tumour suppressive miRNA target PTPN11 in hpopharyngeal squamous cell carcinoma. Br J cancer 2010;103:877-884.
10. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M. The tumor suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J cancer 2010;104:808-818.
11. Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Fujimaru L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, Shozu M, Okamoto T, Seki N. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol 2011;38:209-217.
12. Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Shozu M, Okamoto T, Seki N. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2011;2:29-44.
13. Nohata N, Hanazawa Y, Kikkawa N, Sakurai D, Fujimura L, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Katayama A, Harabuchi Y, Okamoto T, Seki N. Tumor suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br J cancer 2011;105:833-841.
14. Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. urologic oncology 2010 [in press].
15. Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M. miR-218 on the genomic loss region of chromosome 4p15.31 function as a tumor suppressor in bladder cancer. Int J Oncol 2011;39:13-21.
16. Kwakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Ichiro Kagara, Gotanda T, Tachiwada T, Nishiyama K, Nohata N, Seki N, Nakagawa M. The functional significance of MiR-1 and miR-133a in renal cell carcinoma. Eur J Cancer 2011 [in press].
17. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimaru L, Kikkawa N, Seki N, Nakagawa M. miR-145 and miR-133a function as tumour suppressors and directly regulated FSCN1 expression in bladder cancer. Br J Cancer 2010;102:883-891
18. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncl 2011;39:1099-1107.
19. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST. Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008;68:5049-5058.
20. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Wang B, Suster S, Jacob ST, Ghoshal K. Down-regulation of miro-RNA-1(miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 2008;283:33394-333405.
21. Yan D, Dong Xda E, Chen X, Wang L, Lu C, Wang J, Qu J, Tu L. MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J Bio Chem 2009;284:29596-29604
22. Uchida Y, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Kawahara K, Nishiyama K, Seki N, Nakagawa M. MiR-133s induced apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol 2010 [in press].
23. Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D, Gimotty PA, Klein-Szanto AJ, Diehl JA, Herlyn M, Nakagawa H. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 2011;71:6836-6847.
24. Inge de Kinger, Leonie JM Mekenkamp, Comelis JA Punt, Iris D Nagtegaal. MicroRNAs in colorectal cancer metastasis. J Pathol 2011;224:438-447.
25. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Yousef GM. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 2011;186:1077-1083.
26. R.D. Morin, Michael D, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, Eaves C, Marra M. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 2008;18:610-621.
27. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are answers in sight? Nat Rev Genet 2008;9:102-114.
28. Folk JE. Transglutaminase. Annu Rev Biochem 1980;49:517-531.
29. Lorand L, Graham RM. Transglutaminase crossing enzyme with pleiotropic functions. Nat Rev Mol Cell Biol 2003;4:140-156.
30. Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K. Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res 2006;66:10525-10533.
31. Mehta K, Fok J, Miller FR, Koul D, Sahin AA. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 2004;10:8068-8076.
32. Fok JY, Ekmekcoglu S, Mehta K. Implications of tissue transglutaminase expression in malignant melanoma. Mol Cancer Ther 2006;5:1493-1503
33. Hwang JY, Mangala LS, Fok JY, Lin YG, Merrit WM, Spannuth WA, Nick AM, Fiterman DJ, Vivas-Mejia PE, Deavers MT, Coleman BL, Lopez-Berestein G, Mehta K, Sood Ak. Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. Cancer Res 2008;68:5849-5858.
34. Park KS, Kim HK, Lee JH, Choi YB, Park SY, Yang SH, Kim SY, Hong KM. Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer. J Cancer Res Clin Oncol 2010;136:493-502.
35. Yuan L, Siegel M, Choi K, Khosla V, Miller CR, Jacson EN, Piwnica-Worms D, Rich KM. Transglutaminase 2 inhibitor, KCC009,disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 2007;26:2563-2573
36. Verma A, Mehta K. Tissue tansglutaminase-mediated chemoresistance in cancer cells. Drug Resist Updat 2007;10:144-151.
37. Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A, Metha K. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 2007;26:2459-2470.
38. Ai L, Kim WJ, Demircan B, Dyer LD, Bray KJ, Skehan RR, Massoll A, Brown KD. The transglutaminase 2 gene, a potential molecular marker for chemotherapeutic drug sensitivity, is eigenetically silenced in breast cancer. Carcinogenesis 2008;29:510-518.
39. Shao M, Cao L, Shen C, Satpathy M, Chelladurai B, Bigsby RM, Nakshatri H, Matei D. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res 2009;69:9192-9201.
40. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 6th edn. International Union Against Cancer (UICC). Wiley-Liss;2009.p.255-257.